HEADER LIGASE 27-NOV-03 1V66 TITLE SOLUTION STRUCTURE OF HUMAN P53 BINDING DOMAIN OF PIAS-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN INHIBITOR OF ACTIVATED STAT PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-65; COMPND 5 SYNONYM: PROTEIN INHIBITOR OF ACTIVATED STAT-1, PIAS-1, GU BINDING COMPND 6 PROTEIN, GBP, RNA HELICASE II BINDING PROTEIN, DEAD/H BOX-BINDING COMPND 7 PROTEIN 1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS FOUR HELIX BUNDLE, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, KEYWDS 2 RSGI, STRUCTURAL GENOMICS, LIGASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.OKUBO,F.HARA,Y.TSUCHIDA,S.SHIMOTAKAHARA,S.SUZUKI,H.HATANAKA, AUTHOR 2 S.YOKOYAMA,H.TANAKA,H.YASUDA,H.SHINDO,RIKEN STRUCTURAL AUTHOR 3 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 4 27-DEC-23 1V66 1 REMARK REVDAT 3 02-MAR-22 1V66 1 REMARK REVDAT 2 24-FEB-09 1V66 1 VERSN REVDAT 1 07-DEC-04 1V66 0 JRNL AUTH S.OKUBO,F.HARA,Y.TSUCHIDA,S.SHIMOTAKAHARA,S.SUZUKI, JRNL AUTH 2 H.HATANAKA,S.YOKOYAMA,H.TANAKA,H.YASUDA,H.SHINDO JRNL TITL NMR STRUCTURE OF THE N-TERMINAL DOMAIN OF SUMO LIGASE PIAS1 JRNL TITL 2 AND ITS INTERACTION WITH TUMOR SUPPRESSOR P53 AND A/T-RICH JRNL TITL 3 DNA OLIGOMERS JRNL REF J.BIOL.CHEM. V. 279 31455 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15133049 JRNL DOI 10.1074/JBC.M403561200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUENTERT, P. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1V66 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000006255. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LYS A 34 H LEU A 38 1.50 REMARK 500 H ARG A 15 OE1 GLU A 18 1.55 REMARK 500 O VAL A 21 H TYR A 25 1.57 REMARK 500 O ARG A 62 H PHE A 65 1.58 REMARK 500 O GLN A 20 H GLY A 24 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 -166.04 -173.86 REMARK 500 1 SER A 4 32.77 -94.85 REMARK 500 1 ARG A 28 155.88 -44.99 REMARK 500 1 HIS A 31 105.98 -173.47 REMARK 500 1 SER A 50 163.75 -42.60 REMARK 500 2 ALA A 2 128.27 -176.35 REMARK 500 2 SER A 4 -58.87 79.02 REMARK 500 2 ARG A 28 142.50 -38.82 REMARK 500 2 LYS A 30 -151.59 -109.73 REMARK 500 2 HIS A 31 105.97 64.71 REMARK 500 3 ALA A 2 139.35 74.13 REMARK 500 3 ASP A 3 -45.50 -158.04 REMARK 500 3 SER A 4 -56.71 174.36 REMARK 500 3 LYS A 30 -147.69 -95.33 REMARK 500 3 HIS A 31 115.01 69.95 REMARK 500 3 SER A 50 160.70 -41.05 REMARK 500 4 ASP A 3 -43.97 -163.65 REMARK 500 4 SER A 4 -55.75 172.42 REMARK 500 4 HIS A 31 87.84 -178.86 REMARK 500 4 SER A 50 160.34 -48.46 REMARK 500 5 ASP A 3 -45.64 -156.73 REMARK 500 5 SER A 4 -58.74 176.80 REMARK 500 5 ARG A 28 155.97 -44.42 REMARK 500 5 LYS A 30 -152.94 -121.62 REMARK 500 5 HIS A 31 116.03 72.59 REMARK 500 5 SER A 50 163.24 -44.43 REMARK 500 5 ARG A 63 -35.82 -39.40 REMARK 500 6 ASP A 3 -46.65 -150.79 REMARK 500 6 SER A 4 -46.65 173.90 REMARK 500 6 LEU A 14 153.74 -43.26 REMARK 500 6 HIS A 31 92.98 -165.97 REMARK 500 6 SER A 50 165.46 -46.16 REMARK 500 7 SER A 4 -58.94 84.61 REMARK 500 7 LEU A 14 157.36 -40.96 REMARK 500 7 HIS A 31 82.80 -176.32 REMARK 500 7 SER A 50 171.54 -59.53 REMARK 500 8 ALA A 2 108.09 72.06 REMARK 500 8 SER A 4 -59.11 84.68 REMARK 500 8 LEU A 14 154.43 -40.35 REMARK 500 8 HIS A 31 94.28 -171.15 REMARK 500 8 CYS A 49 141.32 62.88 REMARK 500 9 ASP A 3 -45.64 -130.17 REMARK 500 9 SER A 4 -59.36 164.61 REMARK 500 9 LYS A 30 -153.98 -129.00 REMARK 500 9 HIS A 31 112.22 62.41 REMARK 500 10 ASP A 3 -44.13 -163.38 REMARK 500 10 SER A 4 -55.22 171.43 REMARK 500 10 LEU A 14 152.37 -41.69 REMARK 500 11 ALA A 2 146.37 -176.79 REMARK 500 11 ASP A 3 -43.04 -166.86 REMARK 500 REMARK 500 THIS ENTRY HAS 103 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: AR_001000243.1 RELATED DB: TARGETDB DBREF 1V66 A 1 65 UNP O75925 PIAS1_HUMAN 1 65 SEQRES 1 A 65 MET ALA ASP SER ALA GLU LEU LYS GLN MET VAL MET SER SEQRES 2 A 65 LEU ARG VAL SER GLU LEU GLN VAL LEU LEU GLY TYR ALA SEQRES 3 A 65 GLY ARG ASN LYS HIS GLY ARG LYS HIS GLU LEU LEU THR SEQRES 4 A 65 LYS ALA LEU HIS LEU LEU LYS ALA GLY CYS SER PRO ALA SEQRES 5 A 65 VAL GLN MET LYS ILE LYS GLU LEU TYR ARG ARG ARG PHE HELIX 1 1 ALA A 5 MET A 12 1 8 HELIX 2 2 ARG A 15 TYR A 25 1 11 HELIX 3 3 ARG A 33 ALA A 47 1 15 HELIX 4 4 SER A 50 ARG A 64 1 15 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1